Nephro Care India (NCIL), a multi-specialty healthcare provider backed by Deepak Parekh, has reported a substantial 86.07 per cent increase in standalone net profit for the fiscal year ending March 31, 2024.
The company in a press statement on Thursday said that the its profit after tax (PAT) rose to Rs 4.41 crore, up from Rs 2.37 crore in the previous fiscal year.
This impressive growth is attributed to a 59.33 per cent rise in revenue from operations, which reached Rs 27.23 crore in FY 23-24, compared to Rs 17.09 crore in FY 22-23. The company also witnessed a significant 99.41 per cent surge in operating profit (EBITDA), which stood at Rs 6.84 crore, up from Rs 3.43 crore the previous year. The EBITDA margin improved by 505 basis points, reaching 25.10 per cent in FY 23-24.
Dr. Pratim Sengupta, Founder and Managing Director of Nephro Care India, highlighted the increasing demand for specialised renal care in India. He pointed out that around 15 per cent of the population suffers from high blood sugar levels, and 22 per cent from hypertension—both of which significantly increase the risk of developing renal diseases. Despite the growing need, the country’s existing infrastructure remains insufficient to meet the demand for renal care services.
“Our renal care clinics have made progress in bridging the demand-supply gap, but much more needs to be done,” said Dr. Sengupta. “Our mission is to expand our footprint and make quality kidney care accessible even in the most remote parts of the country.”
Government estimates indicate that around 2,20,000 patients in India develop end-stage renal disease (ESRD) annually, leading to an additional demand for 34 million dialysis sessions each year. However, with only about 5,000 dialysis centres nationwide—including 1,353 centres under the Pradhan Mantri National Dialysis Programme (PMNDP)—the country’s capacity is far from adequate to meet this demand.
To address this gap, NCIL plans to expand its network of renal care clinics. Currently operating five clinics in West Bengal, the company aims to establish 22 additional clinics across the country by March 2026, following a hub-and-spoke model. Over the next 10-15 years, NCIL envisions setting up 300 such centres, impacting the lives of close to one million patients suffering from chronic kidney disease, the press statement added.
